Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
A Health Canada safety review was carried out as a follow-up assessment on the potential risk of retinal detachment with …
In 2014, Health Canada completed a first safety review for the Omnipod because a high number of complaints, reporting high …
After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly …
Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval …
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction …
Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared …
Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that …
A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's …
As part of Health Canada's ongoing monitoring of glistening development in IOLs, Health Canada reviewed the available safety information related …
A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use …